1 / 8

RNA Targeting Small Molecules Therapeutics_PDF

Global rna targeting small molecules therapeutics market size is expected to reach $5.09 Bn by 2028 at a rate of 36.9%, segmented as by offering, mrna (messenger ribonucleic acid) translation modulators, rna (ribonucleic acid) splicing modification<br>

shraddhatbrc
Télécharger la présentation

RNA Targeting Small Molecules Therapeutics_PDF

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. RNA Targeting Small Molecules Therapeutics Global Market Report 2024 Global Forecast 2024 – 2033 Market Size, Drivers, And Trends Top Market Research Firm 2023! We are honored to be listed as a top company at the forefront of research, by the Business Management Review © The Business Research Company. All Rights Reserved.

  2. RNA Targeting Small Molecules Therapeutics Market Segments The Business Research Company segments the rna targeting small molecules therapeutics market segments market report as: mRNA (Messenger Ribonucleic Acid) Translation Modulators, RNA (Ribonucleic Acid) Splicing Modification, Direct RNA (Ribonucleic Acid) Targeting, Other Offerings By Source By Technology Lung Fibrosis, Cancer, Neurodegenerative Diseases, Autoimmune, Inflammatory, Other Therapeutic Indications By Therapeutic By Form Indication Drug Discovery, Oncology Research, Disease Identification By Application By Application Hospitals, Research Laboratories, Pharmaceutical And Biotechnology Companies, Other End-Users . By End User . . © The Business Research Company. All Rights Reserved.

  3. Market Statistics The rna targeting small molecules therapeutics market size has grown exponentially in recent years. It will grow from $1.06 billion in 2023 to $1.45 billion in 2024 at a compound annual growth rate (CAGR) of 37.0%. The growth in the historic period can be attributed to drug discovery and development, rising prevalence of rna-related diseases, government and private funding, pharmaceutical industry interest, rna therapeutics success stories.The rna targeting small molecules therapeutics market size is expected to see exponential growth in the next few years. It will grow to $5.09 billion in 2028 at a compound annual growth rate (CAGR) of 36.9%. $5.09 B $1.45 B $1.06 B Click Here To Get A Sample Report © The Business Research Company. All Rights Reserved.

  4. Key Market Drivers And Trends Drivers Surge In Cancer Cases Fuels Expansion Of The Rna-Targeting Small Molecule Therapeutics Market Trends Strategic Partnerships Drive Innovation In The Rna-Targeting Small Molecule Therapeutics Market Region North America was the largest region in the RNA targeting small molecules therapeutics market in 2023. © The Business Research Company. All Rights Reserved.

  5. Top Players In The Market Major companies operating in the RNA targeting small molecules therapeutics market report are F. Hoffmann-La Roche Ltd., Bayer AG, Sanofi S.A., AstraZeneca plc, Eli Lilly and Company, Amgen Inc., Janssen Pharmaceuticals, Celgene Corporation, Vertex Pharmaceuticals, Servier laboratories, Genentech Inc., PTC Therapeutics Inc., Arrakis Therapeutics, Anima Biotech Inc., Skyhawk Therapeutics Inc., Remix Therapeutics, Abivax SA, 858 Therapeutics, Eloxx Pharmaceuticals Inc., STORM Therapeutics Ltd., Accent Therapeutics Inc., eFFECTOR Therapeutics Inc., EPICS Therapeutics, Expansion Therapeutics Inc., Inspirna Inc., MiNA Therapeutics Ltd., Ribometrix Inc., AC Immune SA, Redona Therapeutics. Get More Information On The Market Report © The Business Research Company. All Rights Reserved.

  6. 7 Reasons Why TBRC Is The Solution You Need 1. Global Macroeconomic Impact: Assess global economic factors' influence on market growth. 2. Market Size Ratios: Explore market size, GDP proportions, and expenditure per capita. 3. Global Perspective: Reports cover 60 geographies for a comprehensive global understanding. 4. Localized Strategies: Create region-specific strategies aligning with market nuances. 5. Investment Insights: Identify growth segments through forecast data and market insights. 6. Competitor Benchmarking: Compare performance against key competitors. 7. Presentation Support: Reports offer reliable data for internal and external presentations. © The Business Research Company. All Rights Reserved.

  7. Americas The Business Research Company, 1295 N Providence Rd, Oxygen, PA 19063, USA ✆ +1 3156230293 Get In Touch Europe The Business Research Company 47 Anchorage Point, 42 Cuba Street, Canary Wharf, London, England, E14 8NE How ever you want to grow and expand, The Business Research Company can help as we provide research consulting solutions for businesses, government agencies consultancies, and market research companies. ✆ +44 207 1930 708 Asia The Business Research Company, 1st Floor, Anshu Colors Building, Road Number 1, Park View Enclave, Jubilee Hills, Hyderabad (India), 500033 info@tbrc.info ✆ +91 8897263534 @The Business Research Company. All rights reserved. © The Business Research Company. All Rights Reserved.

  8. Your Growth Insights Partner © The Business Research Company. All Rights Reserved.

More Related